The European Data Protection Board (EDPB) recently adopted its
opinion on the interplay between the Clinical
Trials Regulation 536/2014 (CTR) and the General Data Protection
Regulation 2016/679 (GDPR) (the opinion). The opinion was given at
the request of the European Commission.
The CTR seeks to harmonise the rules for conducting clinical
trials throughout the European Union, and the request for an
opinion stemmed from an acknowledgement of the crucial interplay
between these two pieces of EU legislation. The EDPB emphasised
that interplay by clearing stating in the opinion that the CTR
cannot be used as an exemption for compliance with the GDPR.
The opinion distinguishes between the primary use of data and
the secondary use of data in clinical trials.